Around a half of women in tuberculosis-endemic countries are infected with Mycobacterium tuberculosis and over 1.7 million females of reproductive age (15-45 years) fall ill with tuberculosis (TB) each year. Pregnancy is associated with an increased risk of TB disease which has major consequences for maternal health – TB is the major non-obstetric cause of maternal mortality globally – and for the health of their baby.
There are real challenges in delivering equitable health care in a community, even when there is policy and service goodwill. This is an issue for health services around the world. For the past ten years BiBBS has been working alongside service partners and families to co-design, implement and evaluate multiple early years interventions that are delivered as a part of usual practice in disadvantaged inner-city areas in the UK.
Globally, we face many common challenges. Yet how do we address these in different health contexts to ensure that the right care reaches those who need it the most, in the right way? Decentralisation, localisation, “glocalisation”…many labels been applied to approaches, and debate ensues about which approach is “right”. Yet the aim is common – best care, best outcomes, everywhere.
Spanning the three campus partners, the Centre for the Adolescent Health has driven actions for adolescent health over more than 3 decades, with the aim of understanding and promoting the healthy development of young people, locally and globally. Newly appointed as a Professor of Adolescent Health, Professor Peter Azzopardi will share his personal journey in adolescent health, and in doing so will celebrate the legacy of the late Professor George Patton.
Both RSV and Dengue have proved to be difficult vaccine targets. In both cases vaccine development has taken a very long time, and in both cases some vaccine candidates have led to more severe disease in some individuals. We are currently in the middle of an era of remarkable progress in both fields, but problems remain.
Scientific advances now allow researchers to identify, isolate and engineer stem cells. reNEW aims to deliver treatment outcomes across the breadth of stem cell medicine – new drugs based on human stem cell models, new tissue therapies, and new cell and gene therapies. We look forward to presenting how stem cell medicine and reNEW are advancing treatments for delivery into the clinic across many currently untreatable diseases.
In three parts, this Grand Round intends to describe the significant developments in the management of musculoskeletal conditions associated with cerebral palsy. First, the critical role that the Victorian Cerebral Palsy Register (VCPR) has played in epidemiological research, clinical research, and public health policy will be outlined. The second section will discuss technical developments in the management of Neuromuscular Hip Dysplasia, including novel imaging techniques and new aids for surgeons when considering surgical treatment. The final section will focus on common gait problems in children with cerebral palsy, as well as novel treatment concepts
Is it possible, and is it ethical to resource-adapt cancer treatment developed in high income countries for the benefit of children with cancer living in low- and middle-income settings?
This is the dilemma, and the challenge, faced by health care professionals in such countries who care for 80% of the world’s children who have cancer, and where the chance of cure often remains poor. Adapting cancer treatment is a key pillar of the WHO Global Initiative for Childhood Cancer to improve the cure rates for children with cancer to 60% by 2030.
The term ‘learning health systems’ is not new. But widespread consensus that learning is crucial for health system performance is not matched by shared understanding of how health systems learn. The speaker will present ideas for such shared understanding based on a recent report by the WHO’s Alliance for Health Policy and Systems Research.
Never in the field of health was so much learned by so many in so few months. This Grand Round will recap the lessons from last year, take stock of where we are in February 2022, describe the complex situation with vaccines, and look to what the year might hold for the pandemic and children in Australia and countries around the world.
